Construction and application of model of sudden epilepsy death animal caused by Kcna1 gene knockout
By targeting the Kcna1 gene using CRISPR/Cas9 gene editing technology, a Kcna1 gene knockout mouse model was efficiently constructed, solving the problems of complex and long model construction cycles in existing technologies. This resulted in a stable and economical SUDEP animal model, laying the foundation for SUDEP research.
Patent Information
- Application Number
- CN202410839873.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-26
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The existing technology for constructing Kcna1 gene knockout mouse models is complicated, time-consuming, costly, and the stability of the models has not been confirmed, making it difficult to efficiently construct stable SUDEP animal models.
Using CRISPR/Cas9 gene editing technology, a specific sgRNA was designed to target the entire coding region of the Kcna1 gene. The sgRNA and Cas9 mRNA were co-injected into mouse zygotes to achieve efficient knockout of the Kcna1 gene and construct a homozygous animal model.
It significantly shortened the model construction time, avoided residual Kv1.1 channel function, and the constructed model had good stability, successfully replicating the clinical phenotype of SUDEP, providing an economical and reliable animal model for the study of the pathophysiological mechanism of SUDEP.
Smart Images

Figure CN118956953A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of animal genetic engineering, and in particular to a method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout and an application thereof. Background Art
[0002] Sudden unexpected death in epilepsy (SUDEP) refers to sudden, unexpected, non-traumatic or non-drowning death in patients with epilepsy, with or without witnesses, regardless of whether there is evidence of epileptic seizures, and no other causes of death were found in the autopsy after the documented status epilepticus was excluded. Dlouhy et al. summarized all population-based SUDEP research reports and found that its incidence rate was 0.09‰ to 2.3‰, and the risk of SUDEP in patients with a history of epilepsy was 24 times higher than that in the normal population. Since SUDEP is a sudden fatal disease, the focus of reducing the mortality rate of this disease is prevention. However, there is currently a lack of sufficient understanding of its pathogenesis, making the prevention of the disease a difficult clinical problem. Constructing a stable animal model to study the pathophysiological changes of SUDEP and finding possible intervention targets will help reduce the risk of SUDEP in groups with high-risk factors.
[0003] At present, the animal models used in the field of SUDEP research can be roughly divided into two categories: 1) acute epileptic seizures induced by specific triggering factors such as electrical stimulation and drug intervention, which lead to SUDEP, and 2) genetic epilepsy models with chronic spontaneous epilepsy. The latter is favored by researchers because of its stable inheritance and good reproducibility. The base sequences of human KCNA1 and mouse Kcna1 genes are highly homologous, located at 12p13.32 and 6F3;6 61.57cM, respectively, with 2 exons, encoding the α subunit of the voltage-gated potassium channel Kv1.1, which consists of 6 transmembrane regions, namely S1-S6, intracellular and extracellular connection regions, and N-terminal and C-terminal domains on both sides of the cell. Pathogenic KCNA1 gene mutations are closely related to epileptic seizures and can cause a variety of human diseases such as developmental epileptic encephalopathy and paroxysmal ataxia type I with or without epileptic seizures. Kcna1 homozygous knockout mice have been shown to cause SUDEP and are a good and stable animal model for studying the disease.
[0004] The most internationally recognized Kcna1 homozygous knockout mouse model for SUDEP research was constructed by Sharon L. Smart's team in 1998 using homologous recombination technology. tm1Tem / J, the specific construction process of the gene tool mouse is: replace the entire coding region of the Kcna1 gene with a vector containing the neomycin resistance gene (Neo) in in vitro embryonic stem cell (ES), and finally screen out the ES cells integrated with the Neo gene for in vivo culture. The obtained F0 generation gene mice are chimeric mice. After multiple breeding and screening, mice that can be stably inherited and used for research are obtained. The construction process of the gene tool mouse is relatively complicated, the model construction cycle is long, and the success rate of model construction needs to be improved. The Kcna1 knockout mouse that has been commercialized in the domestic market is obtained based on knocking out the exon 2 sequence of the Kcna1 gene, and the stability of the model has not yet been confirmed.
[0005] Therefore, new technical means are needed to construct a more efficient, simpler, and lower-cost animal model for the study of SUDEP. Summary of the invention
[0006] The present invention provides an efficient, convenient and simple construction method for successfully constructing an animal model of sudden death in epilepsy caused by Kcna1 gene knockout based on CRISPR / Cas9 gene editing technology.
[0007] The specific construction method is as follows:
[0008] (1) Construct two pairs of specific sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4 targeting the mouse Kcna1 gene;
[0009] The sgRNA1 sequence is shown as SEQ.ID.NO.1; the sgRNA2 sequence is shown as SEQ.ID.NO.2; the sgRNA3 sequence is shown as SEQ.ID.NO.3; the sgRNA4 sequence is shown as SEQ.ID.NO.4;
[0010] SEQ.ID.NO.1:GCAATAGAACTCGCTGTTCA TGG ;
[0011] SEQ.ID.NO.2:GGTGCAAGCGAACTCCATGA TGG ;
[0012] SEQ.ID.NO.3:GACCAGCCTTGTCCTAGCGC TGG ;
[0013] SEQ.ID.NO.4:AACACCCTACCTCATTCGCT TGG ;
[0014] (2) constructing a Kcna1 gene targeting vector based on CRISPR / Cas9 gene editing technology using the specific sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4, performing in vitro transcription, and preparing mRNA;
[0015] (3) The sgRNA1-4 and Cas9 mRNA were co-injected into wild-type mouse fertilized eggs, respectively, and the embryos were transplanted into pseudo-pregnant female mice to obtain F0 generation mice. After breeding and identification, a homozygous Kcna1 gene knockout mouse animal model was obtained.
[0016] The breeding scheme is as follows: F0 positive mice are obtained through identification, and the sexually mature F0 positive mice are bred with wild-type mice for the next generation, and F1 positive mice are obtained through identification; sexually mature F1 positive heterozygous mice are bred with each other for the next generation, and a homozygous Kcna1 gene knockout mouse animal model is obtained through identification.
[0017] The identification method is PCR method.
[0018] The detection primer pairs used in the PCR screening are Kcna1-F / Kcna1-R, Kcna1-F3 / Kcna1-R3;
[0019] The Kcna1-F is shown in SEQ.ID.NO.5, Kcna1-R is shown in SEQ.ID.NO.6, Kcna1-F3 is shown in SEQ.ID.NO.7, and Kcna1-R3 is shown in SEQ.ID.NO.8;
[0020] SEQ.ID.NO.5: AATAAGGGATGAATCAGGACAAGGACG;
[0021] SEQ.ID.NO.6: CATGACCAACTTCCAAATGCTCCAT;
[0022] SEQ.ID.NO.7: TTCTAACAGCTTCAGTGGTCAGTGTG;
[0023] SEQ.ID.NO.8: CAAATAGGCCATAATGCTGACTAAGAG;
[0024] The amplification program for screening by the PCR method is: pre-denaturation program at 94°C for 5 minutes; denaturation program at 94°C for 30 seconds, annealing program at 60°C for 30 seconds, extension program at 72°C for 60 seconds / kb, and 35 cycles from denaturation to extension; finally, thorough extension program at 72°C for 5 minutes. After the reaction, the short-term storage is stored at 4°C, and the long-term storage is stored at -20°C.
[0025] The wild-type mice are C57BL / 6N wild-type mice.
[0026] A Kcna1 gene targeting vector, wherein the vector is an sgRNA expression vector based on the CRISPR / Cas9 system, and two pairs of specific sgRNAs targeting the Kcna1 gene are sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4;
[0027] The sgRNA1 sequence is shown as SEQ.ID.NO.1; the sgRNA2 sequence is shown as SEQ.ID.NO.2; the sgRNA3 sequence is shown as SEQ.ID.NO.3; and the sgRNA4 sequence is shown as SEQ.ID.NO.4.
[0028] The Kcna1 gene targeting vector is used to construct an animal model of sudden death in epilepsy caused by Kcna1 gene knockout.
[0029] The application of the Kcna1 gene knockout-induced sudden death in epilepsy animal model constructed by the above-described method in the study of the pathophysiological mechanism of sudden death in epilepsy and related therapeutic targets.
[0030] Compared with the prior art, the beneficial effects of the present invention are:
[0031] 1. The present invention uses CRISPR / Cas9 technology, takes C57BL / 6N as a model animal, and designs gRNA primers to target and knock out the entire coding region of the Kcna1 gene, including exon 1 and exon 2. Based on this construction strategy, on the one hand, compared with the previous homologous recombination technology, the technical solution of the present invention can greatly save the time of animal model construction, and on the other hand, it avoids the residual Kv1.1 channel function that may be caused by the retention of part of the Kcna1 sequence, which affects the phenotype of the knockout model.
[0032] 2. The present invention successfully constructed an animal model of sudden death in epilepsy caused by Kcna1 gene knockout based on CRISPR / Cas9 gene editing technology. The construction method is efficient, convenient and simple. The clinical phenotype of SUDEP was successfully reproduced in the homozygous knockout mouse model of Kcna1 gene constructed by us, confirming the reliability of the model, and providing an economical and reliable animal model for in-depth exploration and revelation of the disease pathological mechanism of Kcna1-related SUDEP and for basic and translational research such as preclinical development of potential drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Figure 1 Schematic diagram of Kcna1 gene knockout strategy;
[0034] Figure 2 Schematic diagram of the mating scheme for Kcna1 knockout mice;
[0035] Figure 3 Schematic diagram of the identification strategy for F0 and F1 generation mice;
[0036] Figure 4 Electropherogram for genotyping of Kcna1 knockout mice;
[0037] Figure 5 This is the partial sequencing result of the F1 generation mouse gene;
[0038] Figure 6 Survival curve and body weight bar graph of Kcna1 gene knockout mouse model;
[0039] Figure 7 Bar graph for qPCR analysis of Kcna1 knockout mouse animal model. DETAILED DESCRIPTION
[0040] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution in the embodiments of the present invention will be described clearly and completely below. It should be noted that if no specific conditions are specified in the examples, they are carried out under normal conditions. The drawings described below are only some embodiments of the present application and do not limit the present invention in any form. For those skilled in the art, several adjustments and improvements can be made without departing from the concept of the present invention. All technologies implemented based on the above content of the present invention belong to the protection scope of the present invention.
[0041] The present invention aims to provide a method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout based on CRISPR / Cas9 technology and its application.
[0042] To achieve the above purpose, the technical scheme adopted by the present invention is: vector design and construction; in vitro transcription of the constructed sgRNA vector and Cas9 vector; co-injection of sgRNA and Cas9 mRNA into C57BL / 6N mouse fertilized eggs; Cas9 protein binds to the target site under the guidance of sgRNA, causing DNA double-strand breaks, thereby achieving Kcna1 gene knockout. This can obtain the first animal model of SUDEP caused by Kcna1 full gene knockout constructed by CRISPR / Cas9 technology in China, which lays a good foundation for further research on its pathophysiological mechanism and possible therapeutic targets.
[0043] Example: Construction of Kcna1 knockout mice
[0044] This embodiment provides a method for constructing an animal model of sudden death in epilepsy caused by Kcna1 gene knockout, which specifically includes the following steps:
[0045] 1. Design of sgRNA
[0046] The mouse Kcna1 gene described in the present invention is located on chromosome 6, with two exons, and the transcript is NM_010595.3. The region from exon 1 to exon 2 is selected as the target site for knockout. In this example, two pairs of different target sites are designed. The schematic diagram of the knockout region is shown in FIG. Figure 1 The specific two pairs of sgRNA sequences are shown in Table 1. Using the sgRNA provided by the present invention can reduce the possibility of off-target effects.
[0047] Table 1 Sequences of sgRNA
[0048]
[0049] 2. The two pairs of sgRNAs, i.e., sgRNA1 / 2 and sgRNA3 / 4, were used to construct sgRNA / Cas9 expression vectors, and mRNA was obtained by in vitro transcription.
[0050] 3. The two pairs of sgRNA and Cas9 mRNA in step 2 were co-injected into different fertilized eggs, and the surviving fertilized eggs were transplanted into pseudo-pregnant female mice to prepare F0 generation mice (see the mating scheme of Kcna1 gene knockout mice for details). Figure 2 ). DNA from the tails of F0 mice at 7-10 days after birth was extracted, PCR amplified and sequenced to obtain two strains of animal models. The specific information is as follows:
[0051] Table 2 Information of positive mice of F0 generation
[0052] ID Genotype identification Mouse Algebra 3 Positive F0 22 Positive F0
[0053] In a specific example, the mouse strain is selected from C57BL / 6N, which is a common inbred strain of experimental mice. The PCR method is used to identify positive mice. The primers, reaction system, and reaction conditions selected for genotyping by PCR are shown in Table 3-5. The identification strategy for F0 and F1 generation mice is shown in Figure 3 .
[0054] Table 3 Genotype identification primer sequences
[0055]
[0056] Note: Two pairs of primers need to be used for PCR separately.
[0057] Table 4 PCR reaction system
[0058]
[0059] Table 5 PCR reaction conditions
[0060]
[0061] 4. The two strains of F0 positive mice obtained in step 3 were mated with wild-type mice to breed F1 mice. The F1 mice were identified as positive heterozygous mice by PCR and DNA sequencing. The identification scheme was the same as that of the F0 mice. The F1 strain mice with stable genetic ability were screened, namely F1 mice #12 and #15.
[0062] The schematic diagram of the two strains of F0 mice mating with wild-type mice to obtain the two strains of F1 mice is shown in Figure 2 The identification strategy of F0 and F1 generation mice can be found in Figure 3 .
[0063] PCR identification results are attached Figure 4 The gene sequencing results of some positive mice in F1 strain 2 are shown in the attached Figure 5 .
[0064] 5. The F1 mice with stable genetic ability obtained in step 4 were mated with each other to breed F2 mice. The identification scheme was the same as that of F0 and F1 mice, and Kcna1 + / + 、Kcna1 + / - 、Kcna1 - / - Three mouse models with different genotypes.
[0065] Effect verification example:
[0066] The animal model constructed in the present invention was used to verify the effect, and the experimental results are shown in Figure 6-Figure 7 .
[0067] Figure 6 -A survival analysis showed that there were significant differences in the survival time of mice with different genotypes. - / - The mouse phenotype has a significantly shorter lifespan than Kcna1 + / + Mouse and Kcna1 + / - Mouse, Kcna1 - / - Mice generally died within 15-45 days. Figure 6 -B Body weight analysis of mice of different genotypes at 13-15 days showed that Kcna1 - / - Mice weighed significantly less than Kcna1 + / + Mouse.
[0068] Depend on Figure 7 -A shows that Kcna1 - / - There is no Kcna1 mRNA expression in the brain, hippocampus, and cerebellum of mice, and Kcna1 + / + The mRNA expression levels of these three brain regions in mice were significantly higher than those of Kcna1 + / - . Figure 7BC is in Kcna1 + / + and Kcna1 + / - In mice, the expression of Kcna1 mRNA in the cerebellum was significantly higher than that in the cerebral cortex and hippocampus.
[0069] In summary, the survival time of the homozygous Kcna1 knockout mice constructed by this method was significantly shorter than that of wild-type and heterozygous mice, and their weight was significantly lighter than that of the latter two types of mice. qPCR experiments further confirmed that there was no Kcna1 mRNA expression in different brain regions of the homozygous Kcna1 knockout mice. The above results prove that the model was successfully constructed and has good stability.
Claims
1. A method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout, characterized in that: The construction method comprises the following steps: (1) Construct two pairs of specific sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4 targeting the mouse Kcna1 gene; The sgRNA1 sequence is shown as SEQ.ID.NO.1; the sgRNA2 sequence is shown as SEQ.ID.NO.2; the sgRNA3 sequence is shown as SEQ.ID.NO.3; the sgRNA4 sequence is shown as SEQ.ID.NO.4; SEQ.ID.NO.1:GCAATAGAACTCGCTGTTCA TGG ; SEQ.ID.NO.2:GGTGCAAGCGAACTCCATGA TGG ; SEQ.ID.NO.3:GACCAGCCTTGTCCTAGCGC TGG ; SEQ.ID.NO.4:AACACCCTACCTCATTCGCT TGG ; (2) constructing a Kcna1 gene targeting vector based on CRISPR / Cas9 gene editing technology using the specific sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4, performing in vitro transcription, and preparing mRNA; (3) The sgRNA1-4 and Cas9 mRNA were co-injected into wild-type mouse fertilized eggs, respectively, and the embryos were transplanted into pseudo-pregnant female mice to obtain F0 generation mice. After breeding and identification, a homozygous Kcna1 gene knockout mouse animal model was obtained.
2. The method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout according to claim 1, characterized in that: After identification, F0 generation positive mice were obtained, and the sexually mature F0 generation positive mice were mated with wild-type mice to breed the next generation, and F1 generation positive mice were obtained after identification; sexually mature F1 generation positive heterozygous mice were mated with each other to breed the next generation, and a homozygous Kcna1 gene knockout mouse animal model was obtained after identification.
3. The method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout according to claim 1, characterized in that: The identification method is PCR method.
4. The method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout according to claim 3, characterized in that: The detection primer pairs used in the PCR screening are Kcna1-F / Kcna1-R, Kcna1-F3 / Kcna1-R3; The Kcna1-F is shown in SEQ.ID.NO.5, Kcna1-R is shown in SEQ.ID.NO.6, Kcna1-F3 is shown in SEQ.ID.NO.7, and Kcna1-R3 is shown in SEQ.ID.NO.8; SEQ.ID.NO.5: AATAAGGGATGAATCAGGACAAGGACG; SEQ.ID.NO.6: CATGACCAACTTCCAAATGCTCCAT; SEQ.ID.NO.7: TTCTAACAGCTTCAGTGGTCAGTGTG; SEQ.ID.NO.8:CAAATAGGCCATAATGCTGACTAAGAG.
5. The method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout according to claim 4, characterized in that: The amplification program for PCR screening is as follows: pre-denaturation program at 94°C for 5 minutes; denaturation program at 94°C for 30 seconds, annealing program at 60°C for 30 seconds, extension program at 72°C for 60 seconds / kb, and 35 cycles from denaturation to extension; finally, thorough extension program at 72°C for 5 minutes. After the reaction, store at 4°C for short-term storage and -20°C for long-term storage.
6. The method for constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout according to claim 1, characterized in that: The wild-type mice are C57BL / 6N wild-type mice.
7. A Kcna1 gene targeting vector, characterized in that: The vector is a sgRNA expression vector based on the CRISPR / Cas9 system, and the two pairs of specific sgRNAs targeting the Kcna1 gene are sgRNA1 / sgRNA2 and sgRNA3 / sgRNA4; The sgRNA1 sequence is shown as SEQ.ID.NO.1; the sgRNA2 sequence is shown as SEQ.ID.NO.2; the sgRNA3 sequence is shown as SEQ.ID.NO.3; and the sgRNA4 sequence is shown as SEQ.ID.NO.
4.
8. Use of the vector according to claim 7 in constructing an animal model of sudden death due to epilepsy caused by Kcna1 gene knockout.
9. Application of the animal model of sudden death in epilepsy caused by Kcna1 gene knockout constructed according to the method of any one of claims 1 to 8 in the study of the pathophysiological mechanism of sudden death in epilepsy and related therapeutic targets.
Citation Information
Patent Citations
Construction method for Sqstm1 whole-genome knockout mouse animal model and application
CN108753783A
PROM1-KO mouse model construction method and application thereof
CN110257435A
Construction method of Amy1 gene knockout mouse animal model and application
CN110885858A
Scn1lab-gene-knocked-out epileptic zebrafish model as well as construction method and application thereof
CN113897362A
Method for constructing animal model capable of causing epilepsy symptom generation through gene knockout and application
CN115838768A
Cited By
Nervous system disease biological model based on Scn1a gene point mutation, construction method and application of nervous system disease biological model
CN121040426A
A biological model of nervous system diseases based on Scn1a gene point mutations, its construction method and its application
CN121040426B
